Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Portfolio Pulse from Lisa Levin
Shares of several companies including TransCode Therapeutics, Fresh Tracks Therapeutics, EBET, Exscientia, Histogen, Rail Vision, Avinger, Inhibikase Therapeutics, Microbot Medical, and Cheche Group are trading higher in pre-market. Fresh Tracks Therapeutics and Histogen announced plans of liquidation and dissolution. Exscientia and Merck announced collaboration on AI-driven drug discovery. Avinger announced the commercial launch of its Tigereye ST image-guided CTO crossing device. On the other hand, shares of ARS Pharmaceuticals, Connexa Sports Technologies, Bird Global, TD Holdings, AgileThought, Elutia, Digital Transformation Opportunities Corp., Cybin, and Revance Therapeutics are trading lower. ARS Pharmaceuticals received a Complete Response Letter from the FDA for its neffy® Epinephrine nasal spray. Bird Global announced its purchase of micromobility operator Skinny Labs for $19 million. Elutia announced a $26 million private placement of shares.
September 20, 2023 | 12:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avinger shares surged on continued strength after the company announced the commercial launch of its Tigereye ST image-guided CTO crossing device.
The announcement of a new product launch is likely to boost investor confidence and lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Exscientia shares jumped after the company and Merck announced collaboration on AI-driven drug discovery.
The announcement of a collaboration with a major company like Merck is likely to boost investor confidence and lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Fresh Tracks Therapeutics shares rose after the company announced its Board of Directors has approved a plan of liquidation and dissolution.
The announcement of liquidation and dissolution usually leads to a short-term increase in stock price as investors try to sell their shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Bird Global shares fell after the company announced its purchase of micromobility operator Skinny Labs for $19 million.
The announcement of a major acquisition can lead to a short-term decrease in stock price as investors may be concerned about the financial impact of the acquisition.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Elutia shares fell after the company announced a $26 million private placement of shares.
The announcement of a private placement can lead to a short-term decrease in stock price as it may dilute the value of existing shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
ARS Pharmaceuticals shares fell after the FDA issued a Complete Response Letter for its neffy® Epinephrine nasal spray.
The issuance of a Complete Response Letter from the FDA is likely to decrease investor confidence and lead to a short-term decrease in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100